The effectiveness of growth hormone replacement on energy expenditure and body composition in patients with adult growth hormone deficiency

• Published in: ENDOCRINE JOURNAL Vol. 68; no. 4; pp. 469 - 475
• Main Authors: Akari Momozono, Akinori Hayashi, Koji Takano, Masayoshi Shichiri
• Format: Journal Article
• Language: Japanese
• Published: The Japan Endocrine Society 2021
• ISSN: 0918-8959; 1348-4540

[Abstract.] Numerous studies have shown that growth hormone (GH) replacement in adult GH deficiency (AGHD) improves the body composition and metabolic rate; however, data about the relationship between body composition and energy expenditure in these patients is scarce. Our study aimed to investigate the changes in resting energy expenditure (REE) and body composition after GH replacement in patients with AGHD. We enrolled 15 patients diagnosed with AGHD and evaluated the effect of GH replacement administered once daily for 12 months on REE, body composition measured by bioelectrical impedance analysis, and serological markers. GH replacement therapy significantly increased the scrum insulin growth factor-1 levels after 4, 8, and 12 months. The REE and REE/basal energy expenditure (REE/BEE) ratio significantly increased from 1278.0+-490.0 kcal/day and 0.87+-0.23 at baseline to 1505.5+-449.2 kcal/day and 1.11+-0.21 at 4 months, 1,918.7+-631.2 kcal/day and 1.29+-0.27 at 8 months, and 1,511.1+-271.2 kcal/day, 1.14+-0.29 at 12 months (p<0.005, p<0.005; p<0.01, p<0.01; p<0.01, p<0.005, respectively). There was no change in the body weight, while the lean body mass increased significantly from 45.8+-9.5 kg at baseline to 46.9+-9.4 kg at 4 months and 47.5+-10.1 kg at 8 months (p<0.005, p<0.01, respectively). The fat mass also decreased at 12 months. Lipid metabolism improved after 4 and 8 months. GH replacement therapy in patients with AGHD significantly improved the REE and body composition.